PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v9i1.9461ArticleSymptom Experiences and Coping Patterns in Pancreatic Cancer Patients During Chemotherapy: A Qualitative Studyhttps://artdesignp.com/journal/PAR/9/1/10.26689/par.v9i1.9461TianXin,ChenPing,ZhouWen,MaoPeiyang,LiJian,LeiCheng,XueXiaojing,LiChanglin,NieYuxuan,GaoFeng,LiJie,FengGang,DuXiaobo,ShiQiuling,ZhangJingyu2025912025-02-13Objective: To explore symptom experiences and self-coping patterns during the early and late stages of chemotherapy in these patients to provide a basis for developing targeted symptom management strategies. Methods: A total of 27 patients with pancreatic cancer undergoing chemotherapy at two medical institutions were recruited between November 2023 and August 2024. Semi-structured interviews were conducted in person or over the phone. Data were analyzed using traditional content and thematic analyses. Results: Three themes were identified: symptom experience, self-coping patterns, and existing obstacles. During the early stages of chemotherapy, patients reported a higher frequency of unpleasant symptoms and recognized these symptoms earlier in the treatment course. Patients in the early stages primarily relied on external support to cope with symptoms, while those in the later stages adopted self-care strategies. Several challenges related to unpleasant symptoms were observed, which appeared to correlate with the self-coping patterns employed. Conclusion: Patients with pancreatic cancer undergoing chemotherapy experience a complex and diverse range of symptoms, with varying coping patterns at different stages of treatment. Symptom management during chemotherapy presents significant challenges. Healthcare providers should improve the ongoing monitoring of symptoms post-chemotherapy. By linking patients’ symptom experiences and self-coping patterns at different stages of chemotherapy to their specific challenges, personalized symptom management strategies can be developed to enhance care quality.

Bray F, Laversanne M, Sung H, et al., 2024, Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 74(3): 229–263. https://doi.org/10.3322/caac.21834

Park W, Chawla A, O’Reilly EM, 2021, Pancreatic Cancer: A Review. JAMA, 326(9): 851–862. https://doi.org/10.1001/jama.2021.13027. Erratum in JAMA, 326(20): 2081. https://doi.org/10.1001/jama.2021.19984

Yu KH, 2024, Advances in Systemic Therapy in Pancreatic Cancer. Hematol Oncol Clin North Am, 38(3): 617–627. https://doi.org/10.1016/j.hoc.2024.03.002

Weiss L, Fischer LE, Heinemann V, et al., 2024, Changes Over Time in the Course of Advanced Pancreatic Cancer Treatment with Systemic Chemotherapy: A Pooled Analysis of Five Clinical Trials from Two Decades of the German AIO Study Group. ESMO Open, 9(4): 102944. https://doi.org/10.1016/j.esmoop.2024.102944

Evans D, Ghassemi N, Hajibandeh S, et al., 2024, Meta-Analysis of Adjuvant Chemotherapy Versus No Adjuvant Chemotherapy for Resected Stage I Pancreatic Cancer. Surgery, 175(6): 1470–1479. https://doi.org/10.1016/j.surg.2023.11.027

Altman AM, Wirth K, Marmor S, et al., 2019, Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer is Uncommon Yet Associated with Improved Survival. Ann Surg Oncol, 26(12): 4108–4116. https://doi.org/10.1245/s10434-019-07602-6

Chen J, Chen L, Yu J, et al., 2019, Meta‑Analysis of Current Chemotherapy Regimens in Advanced Pancreatic Cancer to Prolong Survival and Reduce Treatment‑Associated Toxicities. Mol Med Rep, 19(1): 477–489. https://doi.org/10.3892/mmr.2018.9638

Takeda T, Sasaki T, Mie T, et al., 2021, The Prognostic Impact of Tumour Location and First-Line Chemotherapy Regimen in Locally Advanced Pancreatic Cancer. Jpn J Clin Oncol, 51(5): 728–736. https://doi.org/10.1093/jjco/hyab014

Lelond S, Ward J, Lambert PJ, et al., 2021, Symptom Burden of Patients with Advanced Pancreas Cancer (APC): A Provincial Cancer Institute Observational Study. Curr Oncol, 28(4): 2789–2800. https://doi.org/10.3390/curroncol28040244

Liu C, Liu L, Chen M, 2023, Experience of Living with Symptom Clusters in Postoperative Pancreatic Cancer Patients. Eur J Oncol Nurs, 62: 102266. https://doi.org/10.1016/j.ejon.2022.102266

Tang CC, Draucker C, Tejani M, et al., 2018, Symptom Experiences in Patients with Advanced Pancreatic Cancer as Reported During Healthcare Encounters. Eur J Cancer Care (Engl), 27(3): e12838. https://doi.org/10.1111/ecc.12838

Tang CC, Von Ah D, Fulton JS, 2018, The Symptom Experience of Patients With Advanced Pancreatic Cancer: An Integrative Review. Cancer Nurs, 41(1): 33–44. https://doi.org/10.1097/NCC.0000000000000463

Giesinger JM, Wintner LM, Zabernigg A, et al., 2014, Assessing Quality of Life on the Day of Chemotherapy Administration Underestimates Patients’ True Symptom Burden. BMC Cancer, 14: 758. https://doi.org/10.1186/1471-2407-14-758

Komatsu H, Yagasaki K, Hirata K, et al., 2019, Unmet Needs of Cancer Patients with Chemotherapy-Related Hand-Foot Syndrome and Targeted Therapy-Related Hand-Foot Skin Reaction: A Qualitative Study. Eur J Oncol Nurs, 38: 65–69. https://doi.org/10.1016/j.ejon.2018.12.001

Henly SJ, Kallas KD, Klatt CM, et al., 2003, The Notion of Time in Symptom Experiences. Nurs Res, 52(6): 410–417. https://doi.org/10.1097/00006199-200311000-00009

Rha SY, Park M, Lee J, 2019, Stability of Symptom Clusters and Sentinel Symptoms During the First Two Cycles of Adjuvant Chemotherapy. Support Care Cancer, 27(5): 1687–1695. https://doi.org/10.1007/s00520-018-4413-9

Braun V, Clarke V, 2019, Novel Insights into Patients’ Life-Worlds: The Value of Qualitative Research. Lancet Psychiatry, 6(9): 720–721. https://doi.org/10.1016/S2215-0366(19)30296-2

Zhang J, Wang S, Zhou Z, et al., 2023, Unpleasant Symptoms of Immunotherapy for People with Lung Cancer: A Mixed-Method Study. Int J Nurs Stud, 139: 104430. https://doi.org/10.1016/j.ijnurstu.2022.104430

Livshits Z, Rao RB, Smith SW, 2014, An Approach to Chemotherapy-Associated Toxicity. Emerg Med Clin North Am, 32(1): 167–203. https://doi.org/10.1016/j.emc.2013.09.002

Nunes KZ, Grippa WR, Lopes AB, et al., 2024, Cancer Symptom Clusters, Cardiovascular Risk, and Quality of Life of Patients with Cancer Undergoing Chemotherapy: A Longitudinal Pilot Study. Medicine (Baltimore), 103(16): e37819. https://doi.org/10.1097/MD.0000000000037819

Davis S, Serfaty M, Low J, et al., 2023, Experiential Avoidance in Advanced Cancer: A Mixed-Methods Systematic Review. Int J Behav Med, 30(5): 585–604. https://doi.org/10.1007/s12529-022-10131-4

Yu H, Lei C, Wei X, et al., 2024, Electronic Symptom Monitoring After Lung Cancer Surgery: Establishing a Core Set of Patient-Reported Outcomes for Surgical Oncology Care in a Longitudinal Cohort Study. Int J Surg, 110(10): 6591–6600. https://doi.org/10.1097/JS9.0000000000001855

Mooney K, Whisenant MS, Beck SL, 2019, Symptom Care at Home: A Comprehensive and Pragmatic PRO System Approach to Improve Cancer Symptom Care. Med Care, 57 Suppl 5 Suppl 1(Suppl 5 1): S66–S72. https://doi.org/10.1097/MLR.0000000000001037

Folkman S, Lazarus RS, Gruen RJ, et al., 1986, Appraisal, Coping, Health Status, and Psychological Symptoms. J Pers Soc Psychol, 50(3): 571–579. https://doi.org/10.1037//0022-3514.50.3.571

Silva AVD, Zandonade E, Amorim MHC, 2017, Anxiety and Coping in Women with Breast Cancer in Chemotherapy. Rev Lat Am Enfermagem, 25: e2891. https://doi.org/10.1590/1518-8345.1722.2891

Khan NN, Maharaj A, Evans S, et al., 2022, A Qualitative Investigation of the Supportive Care Experiences of People Living with Pancreatic and Oesophagogastric Cancer. BMC Health Serv Res, 22(1): 213. https://doi.org/10.1186/s12913-022-07625-y

Challinor JM, Alqudimat MR, Teixeira TOA, et al., 2020, Oncology Nursing Workforce: Challenges, Solutions, and Future Strategies. Lancet Oncol, 21(12): e564–e574. https://doi.org/10.1016/S1470-2045(20)30605-7

Temiz G, Durna Z, 2020, Evaluation of Quality of Life and Health Care Needs in Cancer Patients Receiving Chemotherapy. J Cancer Educ, 35(4): 796–807. https://doi.org/10.1007/s13187-019-01533-2

Riegel B, Page SD, Aryal S, et al., 2024, Symptom Characteristics, Perceived Causal Attributions, and Contextual Factors Influencing Self-Care Behaviors: An Ecological Daily Assessment Study of Adults with Chronic Illness. Patient Educ Couns, 123: 108227. https://doi.org/10.1016/j.pec.2024.108227

Maguire R, McCann L, Kotronoulas G, et al., 2021, Real Time Remote Symptom Monitoring During Chemotherapy for Cancer: European Multicentre Randomised Controlled Trial (eSMART). BMJ, 374: n1647. https://doi.org/10.1136/bmj.n1647. Erratum in BMJ, 374: n2116. https://doi.org/10.1136/bmj.n2116